Tiotropium Bromide Inhalation Powder: A Review of its Use in the Management of Chronic Obstructive Pulmonary Disease

Author： Keating Gillian M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.2, 2012-01, pp. : 273-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease

By ZuWallack Alicia R   ZuWallack Richard L  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1827-1835

Informa Healthcare

Access to resources Recommend Favorite

Budesonide/Formoterol Turbuhaler®: A Review of its Use in Chronic Obstructive Pulmonary Disease

By Scott Lesley J.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 395-414

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives

By Mittmann Nicole  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 403-414

Adis International

Access to resources Recommend Favorite

Formoterol plus tiotropium bromide is more effective than either drug alone in patients with acute exacerbation of chronic obstructive pulmonary disease

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease

By Brazinsky S.A.  

Clinical Drug Investigation, Vol. 23, Iss. 3, 2003-01 ,pp. : 181-191

Adis International

Access to resources Recommend Favorite